Laboratory surveillance for wild and vaccine-derived polioviruses - Worldwide, January 2008-June 2009

Morbidity and Mortality Weekly Report

Volumn 58, Issue 34, 2009, Pages 950-954

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLASSIFICATION; FECES; GENETICS; GENOTYPE; HEALTH SURVEY; HUMAN; INFANT; ISOLATION AND PURIFICATION; LABORATORY; ORGANIZATION AND MANAGEMENT; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; SEROTYPING; VIROLOGY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FECES; GENOTYPE; HUMANS; INFANT; LABORATORIES; PARALYSIS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; POPULATION SURVEILLANCE; SEROTYPING; WORLD HEALTH ORGANIZATION;

EID: 69849092352     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. CDC. Laboratory surveillance for wild and vaccine-derived polioviruses-worldwide, January 2007-June 2008. MMWR 2008;57:967-70.
2. CDC. Apparent global interruption of wild poliovirus type 2 transmission. MMWR 2001;50:222-4.
3. CDC. Wild poliovirus type 1 and type 3 importations-15 countries, Africa, 2008-2009. MMWR 2009;58:357-62.
4. CDC. Update on vaccine-derived polioviruses-worldwide, January 2006-June 2007. MMWR 2007;56:996-1001.
5. Kilpatrick DR, Yang C-F, Ching K, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol 2009;47:1939-41.